| Year |
Citation |
Score |
| 2023 |
Tullis JE, Larsen ME, Rumian NL, Freund RK, Boxer EE, Brown CN, Coultrap SJ, Schulman H, Aoto J, Dell'Acqua ML, Bayer KU. LTP induction by structural rather than enzymatic functions of CaMKII. Nature. PMID 37648853 DOI: 10.1038/s41586-023-06465-y |
0.598 |
|
| 2023 |
Rumian NL, Freund RK, Dell'Acqua ML, Coultrap SJ, Bayer KU. Decreased nitrosylation of CaMKII causes aging-associated impairments in memory and synaptic plasticity in mice. Science Signaling. 16: eade5892. PMID 37490545 DOI: 10.1126/scisignal.ade5892 |
0.312 |
|
| 2023 |
Tullis JE, Bayer KU. Distinct synaptic pools of DAPK1 differentially regulate activity-dependent synaptic CaMKII accumulation. Iscience. 26: 106723. PMID 37216104 DOI: 10.1016/j.isci.2023.106723 |
0.433 |
|
| 2023 |
Larsen ME, Buonarati OR, Qian H, Hell JW, Bayer KU. Stimulating β-adrenergic receptors promotes synaptic potentiation by switching CaMKII movement from LTD to LTP mode. The Journal of Biological Chemistry. 104706. PMID 37061000 DOI: 10.1016/j.jbc.2023.104706 |
0.434 |
|
| 2022 |
Cook SG, Rumian NL, Bayer KU. CaMKII T286 phosphorylation has distinct essential functions in three forms of long-term plasticity. The Journal of Biological Chemistry. 102299. PMID 35872016 DOI: 10.1016/j.jbc.2022.102299 |
0.654 |
|
| 2022 |
Brown CN, Rumian NL, Tullis JE, Coultrap SJ, Bayer KU. Aβ-induced synaptic impairments require CaMKII activity that is stimulated by indirect signaling events. Iscience. 25: 104368. PMID 35620430 DOI: 10.1016/j.isci.2022.104368 |
0.326 |
|
| 2021 |
Tullis JE, Buonarati OR, Coultrap SJ, Bourke AM, Tiemeier EL, Kennedy MJ, Herson PS, Bayer KU. GluN2B S1303 phosphorylation by CaMKII or DAPK1: no indication for involvement in ischemia or LTP. Iscience. 24: 103214. PMID 34704002 DOI: 10.1016/j.isci.2021.103214 |
0.361 |
|
| 2021 |
Brown CN, Cook SG, Allen HF, Crosby KC, Singh T, Coultrap SJ, Bayer KU. Characterization of six CaMKIIα variants found in patients with schizophrenia. Iscience. 24: 103184. PMID 34667946 DOI: 10.1016/j.isci.2021.103184 |
0.561 |
|
| 2021 |
Goodell DJ, Tullis JE, Bayer KU. Young DAPK1 knockout mice have altered pre-synaptic function. Journal of Neurophysiology. PMID 33881939 DOI: 10.1152/jn.00055.2021 |
0.345 |
|
| 2021 |
Cook SG, Buonarati OR, Coultrap SJ, Bayer KU. CaMKII holoenzyme mechanisms that govern the LTP versus LTD decision. Science Advances. 7. PMID 33853773 DOI: 10.1126/sciadv.abe2300 |
0.619 |
|
| 2020 |
Buonarati OR, Cook SG, Goodell DJ, Chalmers NE, Rumian NL, Tullis JE, Restrepo S, Coultrap SJ, Quillinan N, Herson PS, Bayer KU. CaMKII versus DAPK1 Binding to GluN2B in Ischemic Neuronal Cell Death after Resuscitation from Cardiac Arrest. Cell Reports. 30: 1-8.e4. PMID 31914378 DOI: 10.1016/J.Celrep.2019.11.076 |
0.533 |
|
| 2019 |
Chalmers NE, Yonchek J, Steklac KE, Ramsey M, Bayer KU, Herson PS, Quillinan N. Calcium/Calmodulin-Dependent Kinase (CaMKII) Inhibition Protects Against Purkinje Cell Damage Following CA/CPR in Mice. Molecular Neurobiology. PMID 31520314 DOI: 10.1007/S12035-019-01765-9 |
0.359 |
|
| 2019 |
Bayer KU, Schulman H. CaM Kinase: Still Inspiring at 40. Neuron. 103: 380-394. PMID 31394063 DOI: 10.1016/j.neuron.2019.05.033 |
0.557 |
|
| 2019 |
Cook SG, Goodell DJ, Restrepo S, Arnold DB, Bayer KU. Simultaneous Live Imaging of Multiple Endogenous Proteins Reveals a Mechanism for Alzheimer's-Related Plasticity Impairment. Cell Reports. 27: 658-665.e4. PMID 30995464 DOI: 10.1016/J.Celrep.2019.03.041 |
0.603 |
|
| 2018 |
Opazo P, Viana da Silva S, Carta M, Breillat C, Coultrap SJ, Grillo-Bosch D, Sainlos M, Coussen F, Bayer KU, Mulle C, Choquet D. CaMKII Metaplasticity Drives Aβ Oligomer-Mediated Synaptotoxicity. Cell Reports. 23: 3137-3145. PMID 29898386 DOI: 10.1016/J.Celrep.2018.05.036 |
0.459 |
|
| 2018 |
Cook SG, Bourke AM, O'Leary H, Zaegel V, Lasda E, Mize-Berge J, Quillinan N, Tucker CL, Coultrap SJ, Herson PS, Bayer KU. Analysis of the CaMKIIα and β splice-variant distribution among brain regions reveals isoform-specific differences in holoenzyme formation. Scientific Reports. 8: 5448. PMID 29615706 DOI: 10.1038/S41598-018-23779-4 |
0.489 |
|
| 2017 |
Woolfrey KM, O'Leary H, Goodell DJ, Robertson HR, Horne EA, Coultrap SJ, Dell'Acqua ML, Bayer KU. CaMKII regulates the de-palmitoylation and synaptic removal of AKAP79/150 to mediate structural LTD. The Journal of Biological Chemistry. PMID 29196604 DOI: 10.1074/Jbc.M117.813808 |
0.516 |
|
| 2017 |
Goodell DJ, Zaegel V, Coultrap SJ, Hell JW, Bayer KU. DAPK1 Mediates LTD by Making CaMKII/GluN2B Binding LTP Specific. Cell Reports. 19: 2231-2243. PMID 28614711 DOI: 10.1016/j.celrep.2017.05.068 |
0.504 |
|
| 2017 |
Myers JB, Zaegel V, Coultrap SJ, Miller AP, Bayer KU, Reichow SL. The CaMKII holoenzyme structure in activation-competent conformations. Nature Communications. 8: 15742. PMID 28589927 DOI: 10.1038/Ncomms15742 |
0.363 |
|
| 2017 |
Deng G, Orfila JE, Dietz RM, Moreno-Garcia M, Rodgers KM, Coultrap SJ, Quillinan N, Traystman RJ, Bayer KU, Herson PS. Autonomous CaMKII Activity as a Drug Target for Histological and Functional Neuroprotection after Resuscitation from Cardiac Arrest. Cell Reports. 18: 1109-1117. PMID 28147268 DOI: 10.1016/J.Celrep.2017.01.011 |
0.303 |
|
| 2016 |
Dosemeci A, Toy D, Burch A, Bayer KU, Tao-Cheng JH. CaMKII-mediated displacement of AIDA-1 out of the postsynaptic density core. Febs Letters. PMID 27477489 DOI: 10.1002/1873-3468.12334 |
0.341 |
|
| 2016 |
Barcomb K, Hell JW, Benke TA, Bayer KU. The CaMKII/GluN2B interaction maintains synaptic strength. The Journal of Biological Chemistry. PMID 27246855 DOI: 10.1074/Jbc.M116.734822 |
0.441 |
|
| 2015 |
Barcomb K, Goodell DJ, Arnold DB, Bayer KU. Live imaging of endogenous CaMKII in neurons reveals that ischemia-related aggregation does not require kinase activity. Journal of Neurochemistry. PMID 26212614 DOI: 10.1111/jnc.13263 |
0.336 |
|
| 2014 |
Thein S, Pham A, Bayer KU, Tao-Cheng JH, Dosemeci A. IKK regulates the deubiquitinase CYLD at the postsynaptic density. Biochemical and Biophysical Research Communications. 450: 550-4. PMID 24928390 DOI: 10.1016/j.bbrc.2014.06.019 |
0.411 |
|
| 2014 |
Coultrap SJ, Bayer KU. Nitric oxide induces Ca2+-independent activity of the Ca2+/calmodulin-dependent protein kinase II (CaMKII). The Journal of Biological Chemistry. 289: 19458-65. PMID 24855644 DOI: 10.1074/jbc.M114.558254 |
0.403 |
|
| 2014 |
Barcomb K, Buard I, Coultrap SJ, Kulbe JR, O'Leary H, Benke TA, Bayer KU. Autonomous CaMKII requires further stimulation by Ca2+/calmodulin for enhancing synaptic strength. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 3810-9. PMID 24843070 DOI: 10.1096/Fj.14-250407 |
0.45 |
|
| 2014 |
Goodell DJ, Eliseeva TA, Coultrap SJ, Bayer KU. CaMKII binding to GluN2B is differentially affected by macromolecular crowding reagents. Plos One. 9: e96522. PMID 24796865 DOI: 10.1371/journal.pone.0096522 |
0.352 |
|
| 2014 |
Turecek J, Yuen GS, Han VZ, Zeng XH, Bayer KU, Welsh JP. NMDA receptor activation strengthens weak electrical coupling in mammalian brain. Neuron. 81: 1375-88. PMID 24656255 DOI: 10.1016/J.Neuron.2014.01.024 |
0.368 |
|
| 2014 |
Coultrap SJ, Freund RK, O'Leary H, Sanderson JL, Roche KW, Dell'Acqua ML, Bayer KU. Autonomous CaMKII mediates both LTP and LTD using a mechanism for differential substrate site selection. Cell Reports. 6: 431-7. PMID 24485660 DOI: 10.1016/j.celrep.2014.01.005 |
0.484 |
|
| 2013 |
Barcomb K, Coultrap SJ, Bayer KU. Enzymatic activity of CaMKII is not required for its interaction with the glutamate receptor subunit GluN2B. Molecular Pharmacology. 84: 834-43. PMID 24056996 DOI: 10.1124/mol.113.089045 |
0.455 |
|
| 2013 |
Yang Y, Tao-Cheng JH, Bayer KU, Reese TS, Dosemeci A. Camkii-mediated phosphorylation regulates distributions of Syngap-α1 and -α2 at the postsynaptic density. Plos One. 8: e71795. PMID 23967245 DOI: 10.1371/journal.pone.0071795 |
0.36 |
|
| 2012 |
Coultrap SJ, Bayer KU. CaMKII regulation in information processing and storage. Trends in Neurosciences. 35: 607-18. PMID 22717267 DOI: 10.1016/j.tins.2012.05.003 |
0.462 |
|
| 2012 |
Coultrap SJ, Barcomb K, Bayer KU. A significant but rather mild contribution of T286 autophosphorylation to Ca2+/CaM-stimulated CaMKII activity. Plos One. 7: e37176. PMID 22615928 DOI: 10.1371/journal.pone.0037176 |
0.392 |
|
| 2011 |
O'Leary H, Liu WH, Rorabaugh JM, Coultrap SJ, Bayer KU. Nucleotides and phosphorylation bi-directionally modulate Ca2+/calmodulin-dependent protein kinase II (CaMKII) binding to the N-methyl-D-aspartate (NMDA) receptor subunit GluN2B. The Journal of Biological Chemistry. 286: 31272-81. PMID 21768120 DOI: 10.1074/Jbc.M111.233668 |
0.454 |
|
| 2011 |
Sanhueza M, Fernandez-Villalobos G, Stein IS, Kasumova G, Zhang P, Bayer KU, Otmakhov N, Hell JW, Lisman J. Role of the CaMKII/NMDA receptor complex in the maintenance of synaptic strength. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 9170-8. PMID 21697368 DOI: 10.1523/JNEUROSCI.1250-11.2011 |
0.393 |
|
| 2011 |
Coultrap SJ, Vest RS, Ashpole NM, Hudmon A, Bayer KU. CaMKII in cerebral ischemia. Acta Pharmacologica Sinica. 32: 861-72. PMID 21685929 DOI: 10.1038/Aps.2011.68 |
0.405 |
|
| 2010 |
Marsden KC, Shemesh A, Bayer KU, Carroll RC. Selective translocation of Ca2+/calmodulin protein kinase IIalpha (CaMKIIalpha) to inhibitory synapses. Proceedings of the National Academy of Sciences of the United States of America. 107: 20559-64. PMID 21059908 DOI: 10.1073/Pnas.1010346107 |
0.464 |
|
| 2010 |
Buard I, Coultrap SJ, Freund RK, Lee YS, Dell'Acqua ML, Silva AJ, Bayer KU. CaMKII "autonomy" is required for initiating but not for maintaining neuronal long-term information storage. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 8214-20. PMID 20554872 DOI: 10.1523/Jneurosci.1469-10.2010 |
0.376 |
|
| 2010 |
Vest RS, O'Leary H, Coultrap SJ, Kindy MS, Bayer KU. Effective post-insult neuroprotection by a novel Ca(2+)/ calmodulin-dependent protein kinase II (CaMKII) inhibitor. The Journal of Biological Chemistry. 285: 20675-82. PMID 20424167 DOI: 10.1074/Jbc.M109.088617 |
0.352 |
|
| 2010 |
Cipolletta E, Monaco S, Maione AS, Vitiello L, Campiglia P, Pastore L, Franchini C, Novellino E, Limongelli V, Bayer KU, Means AR, Rossi G, Trimarco B, Iaccarino G, Illario M. Calmodulin-dependent kinase II mediates vascular smooth muscle cell proliferation and is potentiated by extracellular signal regulated kinase. Endocrinology. 151: 2747-59. PMID 20392834 DOI: 10.1210/En.2009-1248 |
0.324 |
|
| 2010 |
Coultrap SJ, Buard I, Kulbe JR, Dell'Acqua ML, Bayer KU. CaMKII autonomy is substrate-dependent and further stimulated by Ca2+/calmodulin. The Journal of Biological Chemistry. 285: 17930-7. PMID 20353941 DOI: 10.1074/Jbc.M109.069351 |
0.398 |
|
| 2009 |
Vest RS, O'Leary H, Bayer KU. Differential regulation by ATP versus ADP further links CaMKII aggregation to ischemic conditions. Febs Letters. 583: 3577-81. PMID 19840793 DOI: 10.1016/J.Febslet.2009.10.028 |
0.334 |
|
| 2007 |
Vest RS, Davies KD, O'Leary H, Port JD, Bayer KU. Dual mechanism of a natural CaMKII inhibitor. Molecular Biology of the Cell. 18: 5024-33. PMID 17942605 DOI: 10.1091/Mbc.E07-02-0185 |
0.398 |
|
| 2006 |
Bayer KU, LeBel E, McDonald GL, O'Leary H, Schulman H, De Koninck P. Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 1164-74. PMID 16436603 DOI: 10.1523/JNEUROSCI.3116-05.2006 |
0.707 |
|
| 2003 |
Illario M, Cavallo AL, Bayer KU, Di Matola T, Fenzi G, Rossi G, Vitale M. Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation. The Journal of Biological Chemistry. 278: 45101-8. PMID 12954639 DOI: 10.1074/jbc.M305355200 |
0.313 |
|
| 2003 |
Fink CC, Bayer KU, Myers JW, Ferrell JE, Schulman H, Meyer T. Selective regulation of neurite extension and synapse formation by the beta but not the alpha isoform of CaMKII. Neuron. 39: 283-97. PMID 12873385 DOI: 10.1016/S0896-6273(03)00428-8 |
0.548 |
|
| 2003 |
Nori A, Lin PJ, Cassetti A, Villa A, Bayer KU, Volpe P. Targeting of alpha-kinase-anchoring protein (alpha KAP) to sarcoplasmic reticulum and nuclei of skeletal muscle. The Biochemical Journal. 370: 873-80. PMID 12470297 DOI: 10.1042/BJ20021624 |
0.329 |
|
| 2002 |
Leonard AS, Bayer KU, Merrill MA, Lim IA, Shea MA, Schulman H, Hell JW. Regulation of calcium/calmodulin-dependent protein kinase II docking to N-methyl-D-aspartate receptors by calcium/calmodulin and alpha-actinin. The Journal of Biological Chemistry. 277: 48441-8. PMID 12379661 DOI: 10.1074/Jbc.M205164200 |
0.581 |
|
| 2002 |
Bayer KU, De Koninck P, Schulman H. Alternative splicing modulates the frequency-dependent response of CaMKII to Ca(2+) oscillations. The Embo Journal. 21: 3590-7. PMID 12110572 DOI: 10.1093/emboj/cdf360 |
0.659 |
|
| 2001 |
Bayer KU, Schulman H. Regulation of signal transduction by protein targeting: the case for CaMKII. Biochemical and Biophysical Research Communications. 289: 917-23. PMID 11741277 DOI: 10.1006/bbrc.2001.6063 |
0.532 |
|
| 2001 |
Bayer KU, De Koninck P, Leonard AS, Hell JW, Schulman H. Interaction with the NMDA receptor locks CaMKII in an active conformation. Nature. 411: 801-5. PMID 11459059 DOI: 10.1038/35081080 |
0.702 |
|
| 1999 |
Bayer KU, Löhler J, Schulman H, Harbers K. Developmental expression of the CaM kinase II isoforms: ubiquitous gamma- and delta-CaM kinase II are the early isoforms and most abundant in the developing nervous system. Brain Research. Molecular Brain Research. 70: 147-54. PMID 10381553 DOI: 10.1016/S0169-328X(99)00131-X |
0.518 |
|
| 1998 |
Bayer KU, Harbers K, Schulman H. alphaKAP is an anchoring protein for a novel CaM kinase II isoform in skeletal muscle. The Embo Journal. 17: 5598-605. PMID 9755160 DOI: 10.1093/emboj/17.19.5598 |
0.535 |
|
| Show low-probability matches. |
